First 2 Adults with Severe Hemophilia A Respond Well to Gene Therapy in Clinical Trial
Bayer’s investigational gene therapy BAY 2599023 safely and effectively increased the levels of clotting factor VIII (FVIII) and prevented or…
Articles by Marta Figueiredo, PhD
Proper Nutrition Lacking in Children with Hemophilia in Iraqi Province, Study Says
Proper nutrition is lacking in almost half of children with hemophilia in Iraq, with a significant portion of these children underweight…
Hemlibra Safe, Effective in Kids with Hemophilia A Regardless of Inhibitor Status, Data Show
Prophylactic (preventive) treatment with Hemlibra (emicizumab) safely and effectively reduces bleeding rates in children younger than 12 with…
Novo Nordisk Opens Observational Study of How Hemophilia Affects the Brain in Young People
Novo Nordisk is inviting children and young adults with hemophilia A and B to take part in its observational…
Cyklokapron-Feiba Combo Safe and Effective in Treating Acquired Hemophilia A, Study Suggests
A combination of Cyklokapron and Feiba — usually avoided due to a perceived risk of blood clots — appears to…
Excess Weight, Obesity Affecting More Hemophilia Patients, Study Shows
About a third of European and North American hemophilia patients are overweight or obese, which is associated with increased…
Experts Define Recommendations for Best Surgery Management Practices in Hemophilia Patients
A panel of multidisciplinary experts have developed recommendations for applying best practice guidelines in the planning and managing of surgery…
Extended Half-Life Products Double Cost of Hemophilia Treatment, Prime Therapeutics Finds
The cost of hemophilia treatment doubled for patients who switched from standard half-life (SHL) to extended half-life (EHL)…
Catalyst to Present Multidose Data from CB 2679d for Hemophilia B at EAHAD Congress
Catalyst Biosciences recently announced that top-line data from the Phase 1/2 trial of CB 2679d/ISU304 in patients with…